Drug intelligence / Profile preview

fentanyl + propofol + atracurium

Development stage
Unknown
Lead developer
Janssen Pharmaceutica
Modality
Small Molecules
Administration
Intravenous
01

Overview

A combination of **fentanyl**, **propofol**, and **atracurium** is used in clinical anesthesia to achieve deep sedation, analgesia, and muscle relaxation, particularly for procedures such as intubation or surgery. - **Fentanyl** is a potent synthetic opioid analgesic, acting primarily as a mu-opioid receptor agonist, providing strong analgesic and sedative effects[1][2][6]. - **Propofol** is a short-acting intravenous sedative-hypnotic used for the induction and maintenance of anesthesia, with its primary effect as a positive allosteric modulator of the GABA-A receptor, resulting in CNS depression and hypnosis[5]. - **Atracurium** is a non-depolarizing neuromuscular blocking agent that causes skeletal muscle paralysis by competitively inhibiting acetylcholine at the neuromuscular junction[4]. This three-drug combination is commonly used for the induction and maintenance of anesthesia, especially when endotracheal intubation and mechanical ventilation are required. Each drug is titrated to effect, and their combination allows for rapid, controlled anesthesia and muscle relaxation, with fentanyl reducing noxious responses and propofol providing rapid loss of consciousness[2][8], while atracurium ensures muscle relaxation for intubation or surgical access[4].

Other names
fentanyl, propofol, atracurium
02

Targets

Nicotinic Acetylcholine ReceptorMOR (Mu opioid receptor)GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on fentanyl + propofol + atracurium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentanyl + propofol + atracurium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call